Dolby Laboratories (FRA:FUO) Altman Z2-Score: 9.55 (As of Jul. 03, 2026) — 12% Below Median


FRA:FUO Dolby Laboratories Inc FRA:FUO
73 GF Score
Price €45.66
GF Value €76.17
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Dolby Laboratories Altman Z2-Score?

Dolby Laboratories FRA:FUO +0.26% 73 Altman Z2-Score is 9.55 as of Jul. 03, 2026, which is 12% below its 10-year median of 10.82. GuruFocus rates FRA:FUO with a GF Score™ of 73/100 and a GF Value™ of €76.17 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 1,077 Business Services companies, Dolby Laboratories ranks better than 87.09% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

Dolby Laboratories has a Altman Z2-Score of 9.55, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Dolby Laboratories's Altman Z2-Score or its related term are showing as below:

FRA:FUO' s Altman Z2-Score Range Over the Past 10 Years
Min: 9.1   Med: 10.82   Max: 12.36
Current: 9.55

During the past 13 years, Dolby Laboratories's highest Altman Z2-Score was 12.36. The lowest was 9.10. And the median was 10.82.


Dolby Laboratories  (FRA:FUO) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Dolby Laboratories Altman Z2-Score Related Terms


Dolby Laboratories Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Dolby Laboratories's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dolby Laboratories Altman Z2-Score Chart

Dolby Laboratories Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.00 11.22 9.60 9.10 9.85

Dolby Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.36 10.00 9.85 9.87 9.55

FRA:FUO vs AMTM, UNF, AZZ: Altman Z2-Score Comparison

For the Specialty Business Services subindustry, Dolby Laboratories's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dolby Laboratories Altman Z2-Score vs Business Services Industry

For the Business Services industry and Industrials sector, Dolby Laboratories's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Dolby Laboratories's Altman Z2-Score falls into.


FRA:FUO
73GF Score
Dolby Laboratories Inc FRA:FUO
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dolby Laboratories Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Dolby Laboratories's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.2893+3.26*0.8094+6.72*0.0883+1.05*4.2065
=9.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was €2,811 Mil.
Total Current Assets was €1,224 Mil.
Total Current Liabilities was €411 Mil.
Retained Earnings was €2,275 Mil.
Pre-Tax Income was 103.54 + 61.148 + 35.501 + 48.132 = €248 Mil.
Interest Expense was 0 + 0 + 0 + 0 = €0 Mil.
Total Liabilities was €538 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(1223.723 - 410.534)/2810.812
=0.2893

X2=Retained Earnings/Total Assets
=2275.101/2810.812
=0.8094

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(248.321 - 0)/2810.812
=0.0883

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(2264.563 - 0)/538.343
=4.2065

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Dolby Laboratories has a Altman Z2-Score of 9.55 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 9.55 mean?
Dolby Laboratories (FRA:FUO) has a Altman Z2-Score of 9.55 as of Jul. 03, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Dolby Laboratories and its competitors. This is 12% below median its historical median of 10.82. Over the past decade, Dolby Laboratories' Altman Z2-Score has ranged from 9.10 to 12.36. According to the industry distribution chart, Dolby Laboratories ranks #139 out of 1077 companies in the Business Services industry, placing it in the top 12.9%.
Is Dolby Laboratories' Altman Z2-Score too high?
Dolby Laboratories' current Altman Z2-Score of 9.55 is 12% below median its 10-year median of 10.82. Over the past 10 years, this metric has ranged from a low of 9.10 to a high of 12.36. The Business Services industry median Altman Z2-Score is 3.61. Dolby Laboratories' value of 9.55 is 164.5% above this industry median. Based on the distribution chart, Dolby Laboratories ranks #139 out of 1077 companies in the Business Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dolby Laboratories has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dolby Laboratories' Altman Z2-Score compare to AMTM and UNF?
According to the Business Services industry distribution chart, Dolby Laboratories ranks #139 out of 1077 companies for Altman Z2-Score. This places Dolby Laboratories in the top 13% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 3.61. Dolby Laboratories' value of 9.55 is 164.5% above this benchmark. Historically, Dolby Laboratories' own Altman Z2-Score has ranged from 9.10 to 12.36 over the past decade. While the company's 10-year median is 10.82 vs. the industry median of 3.61, Dolby Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Business Services company?
The median Altman Z2-Score among Business Services companies is 3.61, based on 1,077 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dolby Laboratories's current Altman Z2-Score of 9.55 is 164.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Dolby Laboratories and its competitors. For the Business Services industry, the median Altman Z2-Score is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dolby Laboratories's current Altman Z2-Score is 9.55, which is 12% below median its own 10-year median of 10.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dolby Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Dolby Laboratories (FRA:FUO) is currently considered Significantly Undervalued. The stock's GF Value™ is €76.17, compared to a current price of €45.66 — trading 40.1% below its estimated fair value. The current Altman Z2-Score is 9.55, which is 12% below median its 10-year median of 10.82 and 164.5% above the Business Services industry median of 3.61. Dolby Laboratories' overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Dolby Laboratories (FRA:FUO), the current Altman Z2-Score is 9.55 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dolby Laboratories (FRA:FUO) Overvalued in 2026?

Based on GuruFocus' analysis, Dolby Laboratories stock appears to be undervalued. The current stock price of €45.66 is trading 40.1% below its estimated GF Value™ of €76.17. GuruFocus considers Dolby Laboratories to be Significantly Undervalued.

Key valuation signals for FRA:FUO:

  • Altman Z2-Score: 9.55 (12% below median its 10-year median of 10.82)
  • GF Value™: €76.17 vs. price of €45.66 (40.1% below fair value)
  • GF Score™: 73/100 with 2 warning signs
  • Industry Position: 164.5% above the Business Services median (#139 of 1077)

No single metric tells the full story. See the FRA:FUO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dolby Laboratories Business Description

Address 1275 Market Street, San Francisco, CA, USA, 94103-1410
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
73GF Score

Get the complete analysis for FRA:FUO

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€45.66
Price
€76.17
GF Value